Clearmind Medicine, Inc. (CMND)
2.26
-0.20
(-8.13%)
USD |
NASDAQ |
May 22, 16:00
2.25
-0.01
(-0.44%)
After-Hours: 20:00
Clearmind Medicine Shareholders Equity (Quarterly) : 8.238M for Jan. 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -30.27M |
| Pharmagreen Biotech, Inc. | -9.351M |
| Lexaria Bioscience Corp. | 6.602M |
| InMed Pharmaceuticals, Inc. | 6.892M |
| Target Group, Inc. (Canada) | -8.544M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.14M |
| Total Liabilities (Quarterly) | 2.905M |
| Debt to Equity Ratio | 0.001 |
| Current Ratio | 3.794 |
| Net Debt Paydown Yield | 0.28% |